Pricing Log in Create free account

Alzamend Neuro, Inc. (ALZN) vs Kiora Pharmaceuticals, Inc. (KPRX)

Alzamend Neuro, Inc. and Kiora Pharmaceuticals, Inc. are both Biotechnology companies. Alzamend Neuro, Inc. is the larger, with a market value of $7.5M against $6.6M — 1.1× the size. Across the 11 metrics below, Kiora Pharmaceuticals, Inc. leads on 6 and Alzamend Neuro, Inc. on 5.

Valuation

Metric ALZN KPRX Biotechnology median
P/E n/m n/m 10.26
P/S n/m 0.49 9.18
P/B 1.18 0.55 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.05 0.59 0.65
EV/Sales n/m (0.40) 8.98
Earnings yield (150.33%) (166.02%) (34.89%)
Free cash flow yield (104.25%) (93.58%) (24.52%)

Profitability

Metric ALZN KPRX Biotechnology median
Gross margin 0.00% 85.06% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.23%) (56.36%) (50.12%)
Return on assets (122.36%) (39.43%) (45.60%)
Return on invested capital 0.00% (44,053.91%) 0.00%

Growth

Metric ALZN KPRX Biotechnology median
Revenue growth (TTM) — 983.73% 6.26%
EPS growth (last fiscal year) 76.77% (403.45%) 29.88%
Revenue growth, 5-year CAGR — 88.72% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALZN KPRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.01 8.97 4.89
Net debt to EBITDA 0.08 1.33 1.01

Dividend

Metric ALZN KPRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ALZN KPRX Biotechnology median
Market cap 7.48m 6.63m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack